BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Meng Q, Qian J, Li M, Gu C, Yang Y. Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer. Pharmacol Ther 2022;234:108123. [PMID: 35121000 DOI: 10.1016/j.pharmthera.2022.108123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuan M, Jia Y, Xing Y, Wang Y, Liu Y, Liu X, Liu D. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients. Front Genet 2022;13:965033. [DOI: 10.3389/fgene.2022.965033] [Reference Citation Analysis]
2 Zhou X, Du J. CircRNAs: novel therapeutic targets in multiple myeloma. Mol Biol Rep 2022. [PMID: 35729478 DOI: 10.1007/s11033-022-07668-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Salemi M, Mogavero MP, Lanza G, Mongioì LM, Calogero AE, Ferri R. Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA. Cells 2022;11:1930. [PMID: 35741059 DOI: 10.3390/cells11121930] [Reference Citation Analysis]
4 Zhang Y, Wang Y, Ji H, Ding J, Wang K. The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms. J Exp Clin Cancer Res 2022;41:202. [PMID: 35701841 DOI: 10.1186/s13046-022-02403-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]